Dehydroepiandrosterone and/or its metabolites: possible androgen receptor antagonistic effects on digitized mammographic breast density in normal breast tissue of postmenopausal women

References

[1] Birrell SN, Bentel JM, Hickey D, Riciardelli C, Weger MA, Horsfall DI, et al. Androgens induce divergent proliferative response in human breast cell lines. J Steroid Biochem Mol Biol. 1995;52:459–67.10.1016/0960-0760(95)00005-KSuche in Google Scholar

[2] Isakson E, von Schoultz E, Odlind V, Söderqvist, G, Csemiczky G, Carlström K, et al. Effects of oral contraceptives on breast epithelial proliferation. Breast Cancer Res Treat. 2001;65:163–9.10.1023/A:1006482418082Suche in Google Scholar PubMed

[3] Hofling M, Lundström E, Azavedo E, Svane G, Lindén-Hirschberg A, von Schoultz B. Testosterone addition during postmenopausal therapy: effects on mammographic breast density. Climacteric. 2007;10:155–63.10.1080/13697130701258812Suche in Google Scholar PubMed

[4] Hofling M, Löfgren L, von Schoultz E, Carlström K, Söderqvist G. Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue. Gynecol Endocrinol. 2008;24:405–10.10.1080/09513590802193061Suche in Google Scholar PubMed

[5] Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol. 1991;134:818–24.10.1093/oxfordjournals.aje.a116156Suche in Google Scholar PubMed

[6] McCulloch DR, Akl P, Samaratunga H, Herington AC, Odorico DM. Expression of the disintegrin metallo-protease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I and epidermal growth factor in the prostate cancer cell model LNCaP. Clin Cancer Res. 2004;10:314–23.10.1158/1078-0432.CCR-0846-3Suche in Google Scholar

[7] Edwall L, Carlström K, Fianu-Jonasson A. Endocrine status and markers of collagen synthesis and degradation in serum and urogenital tissue from women with and without stress urinary incontinence. Neurourol Urodynam. 2007;26:410–5.10.1002/nau.20335Suche in Google Scholar PubMed

[8] Davies ME, Gumucio JP, Sugg KB, Bedi A, Mendias CL. MMP inhibition as a potential method to augment the healing of skeletal muscle and tendon extracellular matrix. J Appl Physiol. 2013;115:884–91.10.1152/japplphysiol.00137.2013Suche in Google Scholar PubMed PubMed Central

[9] Hulboy DL, Rudolph LA, Matrisian LM. Matrix metalloproteinases as mediators of regulatory function. Mol Hum Reprod. 1997;3:27–45.10.1093/molehr/3.1.27Suche in Google Scholar PubMed

[10] Lundström E, Conner P, Naessén S, Löfgren L, Carlström K, Söderqvist G. Estrone a partial estradiol antagonist in the normal breast. Gynecol Endocrinol. 2015;31:747–9.10.3109/09513590.2015.1062866Suche in Google Scholar PubMed

[11] Chen F, Knecht K, Birzin E, Fisher J, Wilkinson H, Mojena M, et al. Direct agonist/antagonist functions of dehydroepiandrosterone. Endocrinology. 2005;146:4568–76.10.1210/en.2005-0368Suche in Google Scholar PubMed

[12] Lundström E, Christow A, Kersemaekers W, Svane G, Azavedo E, Söderqvist G, et al. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol. 2002;186:717–22.10.1067/mob.2002.121896Suche in Google Scholar PubMed

[13] Lundström E, Lindén Hirschberg A, Söderqvist G. Digitized assessment of mammographic breast density – effect of continuous combined therapy, tibolone and black cohosh compared to placebo. Maturitas. 2011;70:361–4.10.1016/j.maturitas.2011.08.009Suche in Google Scholar

[14] Lundström E, Söderqvist G, Svane G, Azawedo E, Olovsson M, von Schoultz E, et al. Digitized assessment of mammographic breast density in patients who received low dose intrauterine levo-norgestrel in continuous combination with oral estradiol valerate: a pilot study. Fertil Steril. 2006;85:989–95.10.1016/j.fertnstert.2005.09.026Suche in Google Scholar

[15] Hofling M, Carlström K, Svane G, Azavedo E, Klosterboer H, von Schoultz B. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone-binding globulin and free testosterone levels – an association with mammographic density. Gynecol Endocrinol. 2005;20:110–5.10.1080/09513590400021151Suche in Google Scholar PubMed

[16] Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography–mass spectrometry in sera from 116 men, women and children. Clin Chem. 2003;49:1381–95.10.1373/49.8.1381Suche in Google Scholar PubMed

[17] Carlström K, Brody S, Lunell NO, Lagrelius A, Möllerström G, Pousette A, et al. Dehydroepiandrosterone sulfate and dehydroepiandrosterone in serum: age and sex-related differences. Maturitas. 1988;10:297–306.10.1016/0378-5122(88)90065-5Suche in Google Scholar

[18] Eklund E, Berglund B, Labrie F, Carlström K, Ekström L, Hirschberg AL. Serum androgen profile and physical performance in women Olympic athletes. Br J Sports Med. 2017;51:1301–8.10.1136/bjsports-2017-097582Suche in Google Scholar PubMed

[19] Södergård R, Bäckström T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17β to plasma proteins at body temperature. J Steroid Biochem. 1982;16:801–10.10.1016/0022-4731(82)90038-3Suche in Google Scholar PubMed

[20] Naessen T, Sjogren U, Bergquist J, Larsson M, Lind L, Kushnir MM. Endogenous steroids measured by high-specificity liquid chromatography-tandem mass spectrometry and prevalent cardiovascular disease in 70-year-old men and women. J Clin Endocrinol Metab. 2010;95:1889–97.10.1210/jc.2009-1722Suche in Google Scholar PubMed

[21] Zumoff BV, Bradlow HL. Sex difference in the metabolism of dehydroisoandrosterone sulfate. JCEM. 1980;51:334–6.10.1210/jcem-51-2-334Suche in Google Scholar

[22] Crilly RG, Francis RM, Nordin BE. Steroid hormones, ageing and bone. Clin Endocrinol Metab. 1981;10:115–39.10.1016/S0300-595X(81)80041-2Suche in Google Scholar PubMed

[23] Markiewicz L, Gurpide E. C19 adrenal steroids enhance prostaglandin F2α output by human endometrium in vitro. Am J Obstet Gynecol. 1988;159:500–4.10.1016/S0002-9378(88)80117-0Suche in Google Scholar PubMed

[24] Matsuoka LY, Wortsman J, Lifrak ET, Parker LN, Mehta RG, Parker LN. Effect of isotretinoin in acne is not mediated by adrenal androgens. J Am Acad Dermatol. 1989;20:128–9.10.1016/S0190-9622(89)80008-8Suche in Google Scholar PubMed

[25] Longcope C. Dehydroepiandrosterone metabolism. J Endocrinol. 1996;150:125–7.10.1111/j.1749-6632.1995.tb17378.xSuche in Google Scholar PubMed

[26] McNamara KM, Moore NL, Hickey TE, Sasano H, Tilley WD. Complexities of androgen receptor signaling in breast cancer. Endocr Relat Cancer. 2014;21:161–81.10.1530/ERC-14-0243Suche in Google Scholar PubMed

[27] Montt-Guevara MM, Shortrede JE, Giretti MS, Giannini A, Mannella P, Russo E, et al. Androgens regulate T47D cells motility and invasion through actin cytoskeleton remodeling. Front Endocrinol. 2016;7:136.10.3389/fendo.2016.00136Suche in Google Scholar PubMed PubMed Central

[28] Tamimi RM, Hankinson SE, Chen WY, Rosner B, Colditz GA. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Arch Intern Med. 2006;166:1483–9.10.1001/archinte.166.14.1483Suche in Google Scholar PubMed

[29] Glaser RL, Dimitrakakis C. Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study. Maturitas. 2013;76:342–9.10.1016/j.maturitas.2013.08.002Suche in Google Scholar PubMed